The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1

Radwan, Nehal A; Ahmed, Naglaa S

doi:10.1186/1746-1596-7-149

Table 1 Clinicopathological features and the expressions of arginase-1 & HepPar-1 in all studied tumorous cases (no=100)

From: The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1

No	Age	Sex	Histological diagnosis of the tumor	Arginase-1 expression	HepPar-1 expression
1	53	M	Well differentiated HCC	2+	2+
2	45	M	Well differentiated HCC	1+	1+
3	48	M	Well differentiated HCC	2+	2+
4	59	F	Well differentiated HCC	2+	2+
5	60	M	Well differentiated HCC	1+	2+
6	49	M	Well differentiated HCC	2+	1+
7	53	F	Well differentiated HCC	2+	1+
8	55	M	Well differentiated HCC	2+	2+
9	48	M	Well differentiated HCC	2+	2+
10	50	F	Well differentiated HCC	1+	1+
11	52	F	Well differentiated HCC	2+	2+
12	49	M	Moderately differentiated HCC	0	0
13	59	M	Moderately differentiated HCC	2+	2+
14	62	M	Moderately differentiated HCC	1+	1+
15	59	M	Moderately differentiated HCC	1+	1+
16	52	F	Moderately differentiated HCC	2+	2+
17	55	M	Moderately differentiated HCC	1+	1+
18	56	F	Moderately differentiated HCC	2+	2+
19	61	M	Moderately differentiated HCC	1+	0
20	60	M	Moderately differentiated HCC	2+	1+
21	59	M	Moderately differentiated HCC	2+	1+
22	51	M	Moderately differentiated HCC	0	0
23	55	F	Moderately differentiated HCC	2+	2+
24	61	M	Moderately differentiated HCC	1+	1+
25	49	M	Moderately differentiated HCC	2+	2+
26	55	M	Moderately differentiated HCC	1+	0
27	54	M	Moderately differentiated HCC	2+	2+
28	59	F	Moderately differentiated HCC	2+	2+
29	62	M	Moderately differentiated HCC	2+	2+
30	61	M	Moderately differentiated HCC	1+	0
31	50	M	Moderately differentiated HCC	1+	1+
32	48	M	Moderately differentiated HCC	2+	1+
33	52	F	Moderately differentiated HCC	2+	2+
34	60	F	Moderately differentiated HCC	1+	0
35	52	M	Moderately differentiated HCC	2+	2+
36	56	M	Moderately differentiated HCC	1+	1+
37	57	M	Moderately differentiated HCC	0	0
38	58	F	Moderately differentiated HCC	2+	2+
39	65	M	Moderately differentiated HCC	2+	2+
40	55	M	Moderately differentiated HCC (metastatic to chest wall)	1+	1+
41	48	M	Moderately differentiated HCC (metastatic to adrenal gland)	1+	0
42	53	M	Poorly differentiated HCC	0	0
43	57	F	Poorly differentiated HCC	1+	0
44	62	M	Poorly differentiated HCC	0	0
45	65	M	Poorly differentiated HCC	1+	1+
46	50	F	Poorly differentiated HCC	1+	0
47	54	M	Poorly differentiated HCC	0	0
48	56	M	Poorly differentiated HCC	0	0
49	52	M	Poorly differentiated HCC	1+	1+
50	60	M	Poorly differentiated HCC	0	0
51	62	F	Metastatic colonic carcinoma	0	0
52	54	M	Metastatic colonic carcinoma	0	0
53	50	F	Metastatic colonic carcinoma	0	0
54	45	F	Metastatic colonic carcinoma	0	0
55	48	M	Metastatic colonic carcinoma	0	0
56	50	F	Metastatic colonic carcinoma	0	1+
57	57	M	Metastatic colonic carcinoma	0	0
58	49	F	Metastatic colonic carcinoma	0	0
59	55	F	Metastatic colonic carcinoma	0	2+
60	50	M	Metastatic colonic carcinoma	0	0
61	52	M	Metastatic colonic carcinoma	0	0
62	60	M	Metastatic colonic carcinoma	0	0
63	51	M	Metastatic colonic carcinoma	0	0
64	55	F	Metastatic colonic carcinoma	0	2+
65	50	M	Metastatic colonic carcinoma	0	0
66	49	F	Metastatic colonic carcinoma	0	0
67	55	F	Metastatic colonic carcinoma	0	0
68	51	F	Metastatic colonic carcinoma	0	0
69	53	M	Metastatic colonic carcinoma	0	0
70	55	M	Metastatic colonic carcinoma	0	0
71	50	M	Metastatic colonic carcinoma	0	0
72	52	M	Metastatic colonic carcinoma	0	0
73	56	F	Metastatic colonic carcinoma	0	0
74	46	M	Metastatic colonic carcinoma	0	0
75	50	M	Metastatic colonic carcinoma	0	0
76	52	M	Metastatic gastric carcinoma	0	2+
77	49	F	Metastatic gastric carcinoma	0	0
78	55	M	Metastatic gastric carcinoma	0	2+
79	56	M	Metastatic gastric carcinoma	0	0
80	50	M	Metastatic gastric carcinoma	0	1+
81	52	F	Metastatic gastric carcinoma	0	0
82	53	M	Metastatic renal cell carcinoma	0	0
83	55	F	Metastatic renal cell carcinoma	0	0
84	61	M	Metastatic pancreatic carcinoma	1+	0
85	62	M	Metastatic pancreatic carcinoma	0	0
86	60	M	Metastatic lung carcinoma	0	0
87	62	F	Metastatic lung carcinoma	0	0
88	55	M	Metastatic gall bladder carcinoma	0	0
89	60	M	Cholagiocarcinoma	1+	0
90	64	M	Cholagiocarcinoma	0	1+
91	59	M	Cholagiocarcinoma	0	2+
92	64	F	Cholagiocarcinoma	0	0
93	62	F	Cholagiocarcinoma	0	0
94	58	M	Cholagiocarcinoma	0	0
95	62	F	Cholagiocarcinoma	0	0
96	60	M	Cholagiocarcinoma	0	0
97	59	F	Cholagiocarcinoma	0	0
98	65	M	Cholagiocarcinoma	0	0
99	62	M	Cholagiocarcinoma	0	0
100	60	M	Cholagiocarcinoma	0	0

M= male, F= female, HCC= hepatocellular carcinoma, HepPar-1=hepatocyte paraffin antigen-1,(0) =no staining, (1+) =weak staining, (2+) =strong staining.

Back to article page

ISSN: 1746-1596

Contact us

Submission enquiries: journalsubmissions@springernature.com

Diagnostic Pathology

Contact us